4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisMast Cell Activation Disorders, Mastocytosis, Systemic, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, immune system disorder, indolent systemic mastocytosis, mastocytosis, neoplasmRecruitingPhase 2 / Phase 32026-10-07NCT04910685
The OPBC-07/microNAC StudyNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingNot stated2025-01-24NCT06529302
RAdiotherapy With FDG-PET Guided Dose-PAINTing for Primary Head and NeckHead and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasmActive, not recruitingNot applicable2024-12-17NCT04910308
Beyond TME OriginsNeoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasmRecruitingNot applicable2024-10-17NCT02292641